World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
88
Citations
54741
World Ranking
1138
National Ranking
603

Medicine

D-Index
88
Citations
54741
World Ranking
12889
National Ranking
6590

Research.com Recognitions

  • 2019 - Member of the National Academy of Medicine (NAM)

Overview

Kathleen M. Neuzil is affiliated with the University of Maryland, Baltimore in the United States. Their research primarily focuses on the field of Medicine, with significant contributions in Infectious Diseases, Epidemiology, Health, Food Science, and Animal Science and Zoology.

Their work covers various topics, including:

  • SARS-CoV-2 and COVID-19 Research
  • Viral gastroenteritis research and epidemiology
  • COVID-19 Clinical Research Studies
  • Vaccine Coverage and Hesitancy
  • Salmonella and Campylobacter epidemiology
  • Influenza Virus Research Studies
  • SARS-CoV-2 detection and testing

Kathleen M. Neuzil has published frequently in notable scientific venues, including:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • New England Journal of Medicine
  • Clinical Infectious Diseases
  • Vaccine
  • The Journal of Infectious Diseases

Their recent published papers include:

  • An mRNA Vaccine against SARS-CoV-2 - Preliminary Report, 2020, New England Journal of Medicine
  • Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates, 2020, New England Journal of Medicine
  • Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19, 2021, New England Journal of Medicine
  • Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults, 2020, Nature
  • Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial, 2022, Science

The scientist has collaborated extensively with several frequent co-authors, including:

  • Lawrence Corey
  • Dean Follmann
  • Peter B. Gilbert
  • Hana M. El Sahly
  • Lindsey R. Baden

Kathleen M. Neuzil's work has been recognized through membership in the National Academy of Medicine since 2019.

Best Publications

  • Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.

    Lindsey R. Baden;Hana M El Sahly;Brandon J Essink;Karen Kotloff

  • An mRNA Vaccine against SARS-CoV-2 — Preliminary Report

    Lisa A. Jackson;Evan J. Anderson;Nadine G. Rouphael;Paul C. Roberts

  • A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.

    M. N. Oxman;M. N. Oxman;M. J. Levin;G. R. Johnson;K. E. Schmader

  • Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates.

    Edward E. Walsh;Robert W. Frenck;Ann R. Falsey;Ann R. Falsey;Nicholas Kitchin

  • Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19.

    Jerald Sadoff;Glenda Gray;An Vandebosch;Vicky Cárdenas

  • Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults.

    Mark J. Mulligan;Kirsten E. Lyke;Nicholas Kitchin;Judith Absalon

  • Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults.

    Evan J. Anderson;Nadine G. Rouphael;Alicia T. Widge;Lisa A. Jackson

  • The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children.

    Kathleen Maletic Neuzil;Beverly G. Mellen;Peter F. Wright;Edward F. Mitchel

  • Effect of human rotavirus vaccine on severe diarrhea in African infants.

    Shabir A. Madhi;Nigel A. Cunliffe;Duncan Steele;Desirée Witte

  • Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial.

    Peter B Gilbert;Peter B Gilbert;David C Montefiori;Adrian B McDermott;Youyi Fong

  • Impact of Influenza on Acute Cardiopulmonary Hospitalizations in Pregnant Women

    Kathleen Maletic Neuzil;George W. Reed;Edward F. Mitchel;Lone Simonsen

  • Homologous and Heterologous Covid-19 Booster Vaccinations

    Unknown

  • Seasonal Influenza in Adults and Children—Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management: Clinical Practice Guidelines of the Infectious Diseases Society of America

    Scott A. Harper;John S. Bradley;Janet A. Englund;Thomas M. File

  • Effectiveness of pneumococcal polysaccharide vaccine in older adults.

    Lisa A. Jackson;Kathleen M. Neuzil;Onchee Yu;Patti Benson

  • Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination.

    Alicia T. Widge;Nadine G. Rouphael;Lisa A. Jackson;Evan J. Anderson

  • Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial

    George E Armah;Samba O Sow;Robert F Breiman;Robert F Breiman;Michael J Dallas

  • The impact of vaccination on COVID-19 outbreaks in the United States.

    Seyed M Moghadas;Thomas N Vilches;Kevin Zhang;Chad R Wells

  • Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19.

    Nicole Doria-Rose;Mehul S. Suthar;Mat Makowski;Sarah O’Connell

  • Burden of Interpandemic Influenza in Children Younger than 5 Years: A 25-Year Prospective Study

    Kathleen M. Neuzil;Yuwei Zhu;Marie R. Griffin;Kathryn M. Edwards

  • Influenza Vaccination of Pregnant Women and Protection of Their Infants

    Abstr Act;Shabir A. Madhi;Clare L. Cutland;Locadiah Kuwanda

  • Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial

    Unknown

  • Evidence of bias in estimates of influenza vaccine effectiveness in seniors

    Lisa A Jackson;Michael L Jackson;Jennifer C Nelson;Kathleen M Neuzil

Frequent Co-Authors

Marie R. Griffin
Marie R. Griffin Vanderbilt University Medical Center
Shabir A. Madhi
Shabir A. Madhi University of the Witwatersrand
Lisa A. Jackson
Lisa A. Jackson Kaiser Permanente
Eric A. F. Simões
Eric A. F. Simões University of Colorado Denver
A. Duncan Steele
A. Duncan Steele Bill & Melinda Gates Foundation
Barney S. Graham
Barney S. Graham Morehouse School of Medicine
Janet A. Englund
Janet A. Englund Seattle Children's Hospital
Max Ciarlet
Max Ciarlet Novartis (Switzerland)
M. Elizabeth Halloran
M. Elizabeth Halloran Fred Hutchinson Cancer Research Center
David K. Shay
David K. Shay Centers for Disease Control and Prevention

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology opens doors to diverse healthcare careers, including nursing and specialized practitioner roles. For those interested in nursing, exploring the easiest LPN programs to get into can provide a practical starting point. These programs offer accessible routes to gain foundational nursing skills, which complement immunological expertise in clinical settings.

Advancing further, nurse practitioner roles are highly sought after in immunology-related fields. Prospective students should consider the which nurse practitioner program is easiest to determine pathways that balance rigorous training with manageability. This can be crucial for busy professionals or those transitioning careers.

Specialized mental health nursing also ties closely to immunological health, particularly in psychiatric-immune interactions. The online pmhnp programs with clinical placement offer excellent clinical experiences vital for hands-on learning and career readiness.

Cost is another important factor. Those seeking affordable education options should explore the cheapest online pmhnp certificate programs to balance quality training with financial feasibility.

Best Scientists Citing Kathleen M. Neuzil

Trending Scientists

Recently Published Articles